Colony Group’s ResMed RMD Stock Holding History

Colony Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,221	Closed	-$625K	–	793
2021 Q1	$625K	Buy	3,221 +1,189	+59%	+$238K	0.01%	491
2020 Q4	$432K	Buy	+2,032	New	+$405K	0.01%	535

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Colony Group's RMD Position: Q2 2021 in Review

Colony Group sold out of ResMed (RMD) in Q2 2021, closing a stake of 3,221 shares — an estimated $625K sold.

Colony Group first reported a position in RMD in Q4 2020 and held it in 2 quarters. The position peaked at $625K in Q1 2021. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

Colony Group reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
Colony Group sold 3,221 ResMed shares in Q2 2021, an estimated $625K.
Colony Group first reported a position in ResMed in Q4 2020 and held it in 2 quarters.
Colony Group's ResMed position peaked at $625K in Q1 2021.
661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Colony Group's 13F filing for Q2 2021, filed 18 Aug 2021.